Intralesional Treatment of Keloids

Phase 3

Recruiting

• Conditions: Scar, Hypertrophic
• Interventions: Drug: Injection

• Registration Number: NCT06729840
• Lead Sponsor: Sohag University

Brief Summary

Intralesional injection in treatment of keloid

Detailed Description

Our study will include 45 patient diveded into three groups , follow up will done before each session , 3month after the last session using photographing assessment , scoring , dermoscope

Study Timeline

• Status Verified: 2024-12
• Study Start: 2024-12-01
• Study First Submitted: 2024-12-02
• Study First Submitted QC: 2024-12-09
• Last Update Submitted: 2024-12-09
• Study First Posted: 2024-12-11
• Last Update Posted: 2024-12-11
• Primary Completion: 2025-04-01
• Study Completion: 2025-05-02

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 45

Inclusion Criteria

Both sex aged 18-60 having keloid

Exclusion Criteria

• pregnancy , lactation Skin disease

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Group 1	Injection	Will include 15 patients will injected with vitamin D
Group 2	Injection	Will include 15 patients will injected with botulinum toxin type A
Group 3	Injection	Will include 15 patients will injected with triamcinolone acetonide

Primary Outcome Measures

Name	Time	Method
Posas score	One session every two weeks total duration 3 months	patient and observer parameters will be assessed

Trial Locations

Locations (1)

Sohag university hospital; 🇪🇬 Sohag, Egypt